Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,630
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A

Lishan WangDepartment of Maxillofacial Surgery, Weifang City People’s Hospital, Weifang City, Shandong Province, China
,
Shuqing GeDepartment of Maxillofacial Surgery, Weifang City People’s Hospital, Weifang City, Shandong Province, China
&
Futing ZhouDepartment of Maxillofacial Surgery, Weifang City People’s Hospital, Weifang City, Shandong Province, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8917-7176
ORCID Icon
Pages 937-947 | Received 04 Jan 2021, Accepted 28 Jan 2021, Published online: 16 Mar 2021

References

  • He B, Lin X, Tian F, et al. MiR-133a-3p inhibits oral squamous cell carcinoma (OSCC) proliferation and invasion by suppressing COL1A1. J Cell Biochem. 2018;119(1):338–346.
  • Sinevici N, O’Sullivan J. Oral cancer: deregulated molecular events and their use as biomarkers. Oral Oncol. 2016;61:12–18.
  • Morais MO, Elias MR, Leles CR, et al. The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients. Support Care Cancer. 2016;24(4):1663–1670.
  • Alzahrani R, Alrehaili AA. Cancerous Inhibitor of Protein Phosphatase 2A as a Molecular Marker for Aggressiveness and Survival in Oral Squamous Cell Carcinoma. J Cancer Prev. 2020;25(1):21–26.
  • Mücke T, Mitchell DA, Ritschl LM, et al. Influence of tumor volume on survival in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2015;141(6):1007–1011.
  • Mücke T, Wolff K-D, Wagenpfeil S, et al. Immediate microsurgical reconstruction after tumor ablation predicts survival among patients with head and neck carcinoma. Ann Surg Oncol. 2010;17(1):287–295.
  • Chen L, Zhu Q, Lu L, et al. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Bioengineered. 2020;11(1):91–102.
  • Baltimore D, Boldin MP, O’connell RM, et al. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9(8):839.
  • Pang H, Xu X, Dai L, et al. MicroRNA‑195 is associated with regulating the pathophysiologic process of human laryngeal squamous cell carcinoma. Mol Med Rep. 2018;17(4):5283–5291.
  • Si W, Shen J, Zheng H, et al. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019;11(1):25.
  • Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA. Cell. 2013;153(3):516–519.
  • Chang YC, Jan CI, Peng CY, et al. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas. Oncotarget. 2015;6(27):24002–24016.
  • Deng L, Liu H. MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6. Int J Clin Exp Med. 2015;8(2):1862–1870.
  • Lin X, Duan X, Liang YY, et al. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell. 2006;125(5):915–928.
  • Sun W, Yu Y, Dotti G, et al. PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activation. Cell Signal. 2009;21(1):95–102.
  • Zhang Q, Claret FX. Phosphatases: the new brakes for cancer development? Enzyme Res. 2012;2012:659649.
  • Shohat M, Ben-Meir D, Lavi S. Protein phosphatase magnesium dependent 1A (PPM1A) plays a role in the differentiation and survival processes of nerve cells. PloS One. 2012;7(2):e32438.
  • Lammers T, Lavi S. Role of type 2C protein phosphatases in growth regulation and in cellular stress signaling. Crit Rev Biochem Mol Biol. 2007;42(6):437–461.
  • Zhang B, Zhou Z, Lin H, et al. Protein phosphatase 1A (PPM1A) is involved in human cytotrophoblast cell invasion and migration. Histochem Cell Biol. 2009;132(2):169–179.
  • Shao Y, Qu Y, Dang S, et al. MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6. Cancer Cell Int. 2013;13(1):51.
  • Hou Y, Li L, Ju Y, et al. MiR-101-3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2. J Cell Biochem. 2017;118(10):3142–3149.
  • Zhou J, Qie S, Fang H, et al. MiR-487a-3p suppresses the malignant development of pancreatic cancer by targeting SMAD7. Exp Mol Pathol. 2020;116:104489.
  • Wang M, Yu W, Gao J, et al. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1. J Cell Physiol. 2020;235(2):1588–1600.
  • Zurawek M, Dzikiewicz-Krawczyk A, Izykowska K, et al. miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3. Diabetes Res Clin Pract. 2018;142:146–153.
  • Gao J, Zhang L, Liu Z, et al. Effect of miR-135b inhibitor on biological characteristics of osteosarcoma cells through up-regulating PPM1A. Int J Clin Exp Pathol. 2019;12(3):689–699.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.